Denali Therapeutics Company Top Insiders

Denali Therapeutics Management Team Effectiveness

The company has return on total asset (ROA) of (0.2258) % which means that it has lost $0.2258 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3521) %, meaning that it created substantial loss on money invested by shareholders. Denali Therapeutics' management efficiency ratios could be used to measure how well Denali Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.32. The current Return On Capital Employed is estimated to decrease to -0.4. As of now, Denali Therapeutics' Debt To Assets are decreasing as compared to previous years. The Denali Therapeutics' current Asset Turnover is estimated to increase to 0.27, while Total Assets are projected to decrease to under 990.7 M. The current Common Stock Shares Outstanding is estimated to decrease to about 96.2 M. The Denali Therapeutics' current Net Loss is estimated to increase to about (278.7 M)

Denali Therapeutics Workforce Comparison

Denali Therapeutics Insider Trading History

Denali Therapeutics Notable Stakeholders

The success or failure of an entity such as Denali Therapeutics often depends on how effective the management is. Denali Therapeutics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Denali management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Denali management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

When running Denali Therapeutics' price analysis, check to measure Denali Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Denali Therapeutics is operating at the current time. Most of Denali Therapeutics' value examination focuses on studying past and present price action to predict the probability of Denali Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Denali Therapeutics' price. Additionally, you may evaluate how the addition of Denali Therapeutics to your portfolios can decrease your overall portfolio volatility.